Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers
Primary Purpose
Type 2 Diabetes Mellitus
Status
Completed
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
Native palm olein (IV56)
Chemically interesterified palm olein (IV56)
High oleic sunflower oil
Sponsored by

About this trial
This is an interventional prevention trial for Type 2 Diabetes Mellitus focused on measuring Interesterified fat, Stereospecific number 2, Gut hormones, GIP, Insulin sensitivity, Postprandial lipaemia, Haemostatic markers
Eligibility Criteria
Inclusion Criteria:
Mild T2DM individuals not planned for medical intervention
- 7.0 mmol/L ≤ fasting glucose ≤ 11.1 mmol/L
- 6.5% ≤ HbA1c ≤ 9.0%
- Not using antihypertensive, lipid lowering, insulin/glucose modulating medication
Mild T2DM individuals currently on medical intervention
- Fasting glucose ≤ 11.1 mmol/L
- HbA1c ≤ 9.0%
- Using antihypertensive, lipid lowering or glucose modulating medication
- Malaysian male or female with T2DM aged between 30 to 60 years old
- Not using insulin
- Not having any complications of diabetes
- No medical history of myocardial infarction, angina, thrombosis, stroke or cancer
- Haemoglobin levels for females ≥ 11.5 gm/dl and males ≥ 12.5 gm/dl
- Serum ferritin > 15 µg/l at commencement of study
Exclusion Criteria:
- Medical history of myocardial infarction, angina, thrombosis, stroke or cancer
- Underweight (BMI < 18.5 kg/m²)
- Using insulin
- Total cholesterol > 7.0 mmol/L
- Abnormal liver function, renal function and haematology
- Hypersensitive towards heparin
- Gastric or lactose intolerance
- Smoker
- Pregnancy and lactating
- Taking alcohol
- Taking alcohol
- Haemoglobin levels for females ≤ 11.5 gm/dl and males ≤ 12.5 gm/dl
- Serum ferritin < 15 µg/l at commencement of study
Sites / Locations
- Malaysian Palm Oil Board (MPOB)
- Hulu Langat District Health Office
- Sepang District Health Office
- Universiti Putra Malaysia
- Selangor State Health Office
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
Dietary fat - PO
Dietary fat - IPO
Dietary fat - HOS
Arm Description
Native palm olein (IV56)
Chemically interesterified palm olein (IV56)
High oleic sunflower oil
Outcomes
Primary Outcome Measures
6-hour postprandial changes from fasting in glucose-dependent insulinotropic polypeptide (GIP)
To determine the postprandial changes of GIP.
Secondary Outcome Measures
6-hour postprandial changes from fasting in gut hormones
To determine the postprandial changes of ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and cholecystokinin (CCK).
6-hour postprandial changes from fasting in insulinaemic response
To determine the postprandial changes of glucose, insulin, C-peptide and non-esterified fatty acid (NEFA)
6-hour postprandial changes from fasting in lipaemia
To determine the postprandial changes of triacylglycerol (TAG) and apolipoprotein B48 (apoB48).
To compare lipoprotein lipase (LPL) activity, chylomicron fatty acid composition and plasma fatty acid (PFA) composition across meals.
6-hour postprandial changes from fasting in haemostatic response
To determine the postprandial changes of factor FVII activation (FVIIa), plasminogen activator inhibitor-1 (PAI-1)and D-dimer.
To compare pulse wave analysis (PWA) across meals.
6-hour changes from fasting hunger rating using visual analogue scale (VAS)
To determine the changes in hunger rating and food satiety
Full Information
NCT ID
NCT01906359
First Posted
July 11, 2013
Last Updated
October 9, 2015
Sponsor
Malaysia Palm Oil Board
Collaborators
Universiti Putra Malaysia, Ministry of Health, Malaysia
1. Study Identification
Unique Protocol Identification Number
NCT01906359
Brief Title
Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers
Official Title
The Acute Effects of Triacylglycerol Structure of Dietary Fats on Gut Hormones and Haemostatic Markers in Subjects With Type 2 Diabetes Mellitus
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
September 2012 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
March 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Malaysia Palm Oil Board
Collaborators
Universiti Putra Malaysia, Ministry of Health, Malaysia
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Type 2 diabetes mellitus (T2DM) is a chronic disorder determined by lifestyle and genes. It is associated with chronic hyperglycaemia along with other metabolic abnormalities. It is also one of the risk factors for cardiovascular disease (CVD). This disease is due to insulin resistance and/or deficiency as well as increased hepatic glucose output. According to the Third National Health and Morbidity Survey (3rd NHMS), the prevalence of T2DM for adults aged 30 years and above is 14.9%, increased by almost 80% from 1996 to 2006. Dietary composition may affect insulin sensitivity, postprandial triacylglycerol concentration and the risk of T2DM. The role of dietary fats in T2DM is of particular interest and has been clinically studied for many decades. The type of fat we ingest every day consists of different types of fatty acids and different degree of saturation, which in turn influence glucose metabolism by altering cell membrane function, enzyme activity, insulin signalling and gene expression. Previous studies demonstrated that interesterification of dietary fat alter postprandial lipaemia. Saturated fat such as palm olein has been reported to display lower postprandial lipaemia after interesterification. Changing the structure of triacylglycerol (TAG) alters the physical properties of dietary fat which affects digestibility, metabolism and atherogenicity. A recent study conducted by Sanders and co-workers demonstrated reduced levels of plasma glucose-dependent insulinotropic polypeptide (GIP) following both the lard and interesterified palm olein (IPO) compared with the palm olein (PO) and high oleic sunflower oil (HOS) diets in healthy subjects. The GIP and glucagon-like peptide-1 (GLP-1) are major players in the modulation of postprandial insulin secretion by the pancreas. Although GIP secretion in response to meals is normal in patients with Type 2 diabetes mellitus (T2DM), GIP induced secretion of insulin is defective in diabetes. This is observed to be predominantly a defective stimulation of the late phase of insulin response (20-120 minutes). The effect of IPO on GIP may be exaggerated in T2DM patients with impaired insulin sensitivity. Hence, IPO may change the concentrations of gut hormones, postprandial lipaemia, insulinaemic response and CVD related haemostatic markers.
Detailed Description
Subjects aged between 30 and 60 years old (male and female) with Type 2 diabetes mellitus (T2DM) will be recruited for this study. A randomized, crossover, double-blind study design will be carried out to investigate the acute effects of high fat meals prepared using palm olein (PO), chemically interesterified palm olein (IPO) and high oleic sunflower oil (HOS) (control) on study subjects with T2DM. Study subjects will have to undergo three postprandial challenges, separated by at least one week interval. Fasting blood sample and duplicate baseline blood samples will be taken in the morning of postprandial day. After that, subjects will be asked to consume a test meal consisting a high fat muffin baked using the aforementioned oils and a milkshake within 10 minutes. After meal, venous blood samples will be taken at time-points 15, 30, 60, 90, 120 min, 3 h, 4 h, 5 h, 6 h and post-heparin plasma 5 min and 15 min for analysis. Pulse wave analysis will be conducted to evaluate central blood pressure and arterial stiffness. Meal appreciation will be assessed by utilising visual analogue scale (VAS) before eating, after eating and at each time-point.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
Interesterified fat, Stereospecific number 2, Gut hormones, GIP, Insulin sensitivity, Postprandial lipaemia, Haemostatic markers
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
23 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dietary fat - PO
Arm Type
Experimental
Arm Description
Native palm olein (IV56)
Arm Title
Dietary fat - IPO
Arm Type
Experimental
Arm Description
Chemically interesterified palm olein (IV56)
Arm Title
Dietary fat - HOS
Arm Type
Experimental
Arm Description
High oleic sunflower oil
Intervention Type
Other
Intervention Name(s)
Native palm olein (IV56)
Other Intervention Name(s)
PO
Intervention Description
Test meal consists of a high fat muffin (containing 50 g native palm olein) and a cup of milkshake, to be taken as breakfast for each postprandial study day.
Intervention Type
Other
Intervention Name(s)
Chemically interesterified palm olein (IV56)
Other Intervention Name(s)
IPO
Intervention Description
Test meal consists of a high fat muffin (containing 50 g chemically interesterified palm olein) and a cup of milkshake, to be taken as breakfast for each postprandial study day.
Intervention Type
Other
Intervention Name(s)
High oleic sunflower oil
Other Intervention Name(s)
HOS
Intervention Description
Test meal consists of a high fat muffin (containing 50 g high oleic sunflower oil) and a cup of milkshake, to be taken as breakfast for each postprandial study day.
Primary Outcome Measure Information:
Title
6-hour postprandial changes from fasting in glucose-dependent insulinotropic polypeptide (GIP)
Description
To determine the postprandial changes of GIP.
Time Frame
0, 15, 30, 60, 90, 120 min, 3, 4, 5, 6 hour
Secondary Outcome Measure Information:
Title
6-hour postprandial changes from fasting in gut hormones
Description
To determine the postprandial changes of ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and cholecystokinin (CCK).
Time Frame
0, 15, 30, 60, 90, 120 min, 3, 4, 5, 6 h
Title
6-hour postprandial changes from fasting in insulinaemic response
Description
To determine the postprandial changes of glucose, insulin, C-peptide and non-esterified fatty acid (NEFA)
Time Frame
0, 15, 30, 60, 90, 120 min, 3, 4, 5, 6 hour
Title
6-hour postprandial changes from fasting in lipaemia
Description
To determine the postprandial changes of triacylglycerol (TAG) and apolipoprotein B48 (apoB48).
To compare lipoprotein lipase (LPL) activity, chylomicron fatty acid composition and plasma fatty acid (PFA) composition across meals.
Time Frame
0, 1, 2, 3, 4, 5, 6 hour for TAG and apoB48; 6 hour postheparin for LPL; pooled 3, 4, 5 hour for chylomicron and PFA
Title
6-hour postprandial changes from fasting in haemostatic response
Description
To determine the postprandial changes of factor FVII activation (FVIIa), plasminogen activator inhibitor-1 (PAI-1)and D-dimer.
To compare pulse wave analysis (PWA) across meals.
Time Frame
0, 2, 4, 6 hour for FVIIa, PAI-1 and D-dimer; 0, 4 hour for PWA
Title
6-hour changes from fasting hunger rating using visual analogue scale (VAS)
Description
To determine the changes in hunger rating and food satiety
Time Frame
0, 15, 30, 60, 90, 120 min, 3, 4, 5, 6 hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Mild T2DM individuals not planned for medical intervention
7.0 mmol/L ≤ fasting glucose ≤ 11.1 mmol/L
6.5% ≤ HbA1c ≤ 9.0%
Not using antihypertensive, lipid lowering, insulin/glucose modulating medication
Mild T2DM individuals currently on medical intervention
Fasting glucose ≤ 11.1 mmol/L
HbA1c ≤ 9.0%
Using antihypertensive, lipid lowering or glucose modulating medication
Malaysian male or female with T2DM aged between 30 to 60 years old
Not using insulin
Not having any complications of diabetes
No medical history of myocardial infarction, angina, thrombosis, stroke or cancer
Haemoglobin levels for females ≥ 11.5 gm/dl and males ≥ 12.5 gm/dl
Serum ferritin > 15 µg/l at commencement of study
Exclusion Criteria:
Medical history of myocardial infarction, angina, thrombosis, stroke or cancer
Underweight (BMI < 18.5 kg/m²)
Using insulin
Total cholesterol > 7.0 mmol/L
Abnormal liver function, renal function and haematology
Hypersensitive towards heparin
Gastric or lactose intolerance
Smoker
Pregnancy and lactating
Taking alcohol
Taking alcohol
Haemoglobin levels for females ≤ 11.5 gm/dl and males ≤ 12.5 gm/dl
Serum ferritin < 15 µg/l at commencement of study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kim Tiu Teng, PhD
Organizational Affiliation
Malaysian Palm Oil Board (MPOB)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Malaysian Palm Oil Board (MPOB)
City
Kajang
State/Province
Selangor
ZIP/Postal Code
43000
Country
Malaysia
Facility Name
Hulu Langat District Health Office
City
Kajang
State/Province
Selangor
ZIP/Postal Code
43100
Country
Malaysia
Facility Name
Sepang District Health Office
City
Sepang
State/Province
Selangor
ZIP/Postal Code
43900
Country
Malaysia
Facility Name
Universiti Putra Malaysia
City
Serdang
State/Province
Selangor
ZIP/Postal Code
43400
Country
Malaysia
Facility Name
Selangor State Health Office
City
Shah Alam
State/Province
Selangor
ZIP/Postal Code
40100
Country
Malaysia
12. IPD Sharing Statement
Citations:
PubMed Identifier
29872922
Citation
Mo SY, Lai OM, Chew BH, Ismail R, Bakar SA, Jabbar NA, Teng KT. Interesterified palm olein lowers postprandial glucose-dependent insulinotropic polypeptide response in type 2 diabetes. Eur J Nutr. 2019 Aug;58(5):1873-1885. doi: 10.1007/s00394-018-1738-6. Epub 2018 Jun 5.
Results Reference
derived
Learn more about this trial
Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers
We'll reach out to this number within 24 hrs